Filters

Anti-C13orf38 (Polyclonal), ALEXA Fluor 594

Anti-C13orf38 (Polyclonal), ALEXA Fluor 594 size: 100 microliters 489

Supplier BIOSS POLYCLONAL ANTIBODIES
Price 489
Size 100 microliters
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
TypeConjugated Primary Antibody
Conjugated with 594, ALEXA FLUOR®
Host organismRabbit (Oryctolagus cuniculus)
Target Protein/PeptideC13orf38
SpecificityThis antibody reacts specifically with C13orf38
ModificationNo modification has been applied to this antibody
Modification siteNone
ClonalityPolyclonal Antibody
ClonePolyclonal Antibodies
Concentration1ug per 1ul
Subcellular locationsN/A
Antigen SourceKLH conjugated synthetic peptide derived from human C13orf38
Gene IDN/A
Swiss ProtN/A
ApplicationsIF(IHC-P)
Applications with corresponding dilutionsIF(IHC-P)(1:50-200)
Cross reactive species Mouse (Mus musculus), Rat (Rattus norvegicus), Human (Homo sapiens)
Cross Reactive Species details However, note that due to limited knowledge it is impossible to predict with 100% guarantee that the antibody does not corss react with any other species, No significant cross reactivity has been observed for this antibody for the tested species
Background information As with most chromosomes, BRCA2, Key tumor suppressor genes on chromosome 13 include the breast cancer susceptibility gene, RB1 encodes a crucial tumor suppressor protein which, The LOC728591 gene product has been provisionally designated LOC728591 pending further characterization, The gene SLITRK1, Trisomy 13, also known as Patau syndrome, and the RB1 (retinoblastoma) gene, chromosome 13 contains around 114 million base pairs and 400 genes, difficulty eating and vulnerability to serious respiratory infections, is on chromosome 13, is quite deadly and the few who survive past one year suffer from permanent neurologic defects, leads to malignant growth in the retina and has been implicated in a variety of other cancers, polysomy of part or all of chromosome 13 is deleterious to development and decreases the odds of survival, when defective, which is associated with Tourette syndrome, Comprising nearly 4% of human DNA
Purification methodPurified by Protein A
Storage 50% glycerol and 0, Store at 4°, 09% sodium azide, C for 12 months, Water buffered solution containing 100ug/ml BSA
Excitation emission590nm/617nm
Synonyms RP11-251J8, 1 LOC728591
Also known asC13orf38 Polyclonal Antibody
Other nameAnti-C13orf38 Polyclonal
Advisory For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, specificity and sensitivity, thus reducing its reactivity, Avoid freeze/thaw cycles as they may denaturate the polypeptide chains of the antibody
PropertiesFor facs or microscopy Alexa 1 conjugate
ConjugationAlexa Fluor
GroupPolyclonals and antibodies
About The advantage is that there are more epitopes available in a polyclonal antiserum to detect the proteins than in monoclonal sera, immunohistochemistry on frozen slices or parrafin fixed tissues, Polyclonals can be used for Western blot
Gene targetC13orf38
Short nameAnti-C13orf38 (Polyclonal) Fluor 594
Technique Pabs are a collection of immunoglobulin , Polyclonal antibodies , each identifying a different , whereas , (pAbs) are mostly rabbit or goat , B cells, Polyclonal, antibodies , antigen, come from a single N cell lineage, epitope, molecules that react against a specific , monoclonal antibodies , that are secreted by different 
LabelALEXA
Alternative name ALEXA Fluor 594, antibody to-C13orf38 (polyclonal)
Alternative techniquepolyclonals
Identity 34361
Gene CCDC169
Long gene name coiled-coil domain containing 169
Synonyms gene C13orf38
Synonyms gene name chromosome 13 open reading frame 38
Locus 13q13, 3
Discovery year 2008-07-02
Entrez gene record 728591
RefSeq identity NM_001144981
Havana BLAST/BLAT OTTHUMG00000016731

Similar products

Subscribe to our Newsletter